Shandong Sanyuan Biotechnology Co.,Ltd.

SZSE:301206.SZ

27.83 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q1
Revenue 184.159191.118147.555115.879119.037116.276111.542106.086184.679272.598369.96518.466523.401263.493221.237210.132210.2141.613141.802141.80296.57896.578104.507103.10450.47434.11834.03434.03431.29219.36225.48425.48418.62118.62112.09512.0957.9447.944
Cost of Revenue 165.529175.076136.826114.264114.254120.781117.478102.682153.441206.445244.357263.942463.53170.904133.689115.863202.59188.39374.6574.6554.75154.75163.81761.91235.17423.64422.87222.87220.56914.5918.09318.09312.93912.9399.6069.6066.8026.802
Gross Profit 18.6316.04210.7281.6154.783-4.504-5.9363.40431.23866.153125.603254.52459.87192.58987.54894.277.60853.2267.15267.15241.82741.82740.6941.19215.310.47411.16211.16210.7234.7717.3917.3915.6825.6822.4892.4891.1421.142
Gross Profit Ratio 0.1010.0840.0730.0140.04-0.039-0.0530.0320.1690.2430.340.4910.1140.3510.3960.4490.0360.3760.4740.4740.4330.4330.3890.40.3030.3070.3280.3280.3430.2460.290.290.3050.3050.2060.2060.1440.144
Reseach & Development Expenses 13.73315.83312.75615.0669.77311.7892.2089.67711.97310.2210.38720.0416.99510.1173.06312.312006.7746.7742.952.955.8095.8093.36802.5992.5990000000000
General & Administrative Expenses -1.5854.941-8.32510.133-1.6072.391-6.3778.954-0.9093.062-7.00315.192.4312.292-24.6795.508003.1263.1260.5730.5731.2511.2730.3731.6820.7810.7810.3970.4160.4950.4951.1471.1471.2071.2070.7750.775
Selling & Marketing Expenses 1.6261.2341.9171.2211.4860.9581.5930.9361.4021.2631.9221.4411.2170.8881.5080.759006.626.621.7691.7694.064.061.580.9551.1641.1640.7650.5610.5090.5090.4770.4770.3080.3080.2470.247
SG&A 6.2116.1595.89211.354-0.1213.349-4.7859.890.4944.325-5.08216.6313.7162.855-23.176.267009.8189.8182.3012.3015.4165.3331.2062.6371.9451.9451.1620.9771.0041.0041.6241.6241.5151.5151.0221.022
Other Expenses 0.0560.068-4.3350.0650.0110.103-0.2530.001-1.880.0350.118-1.433141.224-183.6927.216-0.90273.152-95.09800000000000000000000
Operating Expenses 19.94421.99322.98320.80116.28815.2325.18715.39710.90814.9510.47226.968141.224-183.698.4916.04873.152-95.09824.96124.9615.2925.29211.28710.8774.5492.8534.9084.9081.3431.1921.3731.3731.5991.5991.4321.4321.2061.206
Operating Income -1.314-5.95-12.2548.48723.50912.87616.16531.49766.43771.954109.633229.24201.09579.80472.58173.26980.76146.51549.2949.2936.44736.44728.84429.63910.5787.6276.4046.4049.2593.5065.9455.9453.9673.9670.9740.9740.0720.072
Operating Income Ratio -0.007-0.031-0.0830.0730.1970.1110.1450.2970.360.2640.2960.4420.3840.3030.3280.3490.3840.3280.3480.3480.3770.3770.2760.2870.210.2240.1880.1880.2960.1810.2330.2330.2130.2130.080.080.0090.009
Total Other Income Expenses Net 31.87331.45728.9490.0650.0110.103-0.2530.001-1.880.0350.11800.0030.004-1.785-0.9020.007-0.3-6.754-6.7540.0880.0880.9620.6770.173-0.005-0.149-0.1490.1210.0740.1340.1340.1170.1170.1080.108-0.135-0.135
Income Before Tax 30.55925.50716.6958.55123.5212.97915.91131.49864.55771.989109.751229.241201.09879.80770.79672.36680.76746.21542.53642.53636.53536.53529.80630.31510.7517.6216.2556.2559.383.586.0786.0784.0844.0841.0821.082-0.063-0.063
Income Before Tax Ratio 0.1660.1330.1130.0740.1980.1120.1430.2970.350.2640.2970.4420.3840.3030.320.3440.3840.3260.30.30.3780.3780.2850.2940.2130.2230.1840.1840.30.1850.2390.2390.2190.2190.0890.089-0.008-0.008
Income Tax Expense 2.771.195-0.540.195-1.9895.1713.381-0.4798.1449.22315.01831.44827.67310.34210.4029.80210.9886.385.7635.7635.1545.1544.1154.1151.0341.1420.9410.9411.4070.5370.9020.9020.0350.0350000
Net Income 27.66624.24817.2028.35625.5097.80812.53131.97656.41462.76694.732197.793173.42569.46560.39462.56569.77939.83536.77336.77331.3831.3825.69126.29.7186.4795.3145.3147.9733.0435.1775.1774.0494.0491.0821.082-0.063-0.063
Net Income Ratio 0.150.1270.1170.0720.2140.0670.1120.3010.3050.230.2560.3810.3310.2640.2730.2980.3320.2810.2590.2590.3250.3250.2460.2540.1930.190.1560.1560.2550.1570.2030.2030.2170.2170.0890.089-0.008-0.008
EPS 0.140.120.0850.0410.130.0390.0620.160.280.510.470.981.140.460.610.6100.260.270.270.520.520.170.180.270.0650.050.050.0980.040.0880.0880.0680.0680.0120.012-0.002-0.002
EPS Diluted 0.140.120.0850.0410.130.0390.0620.160.280.510.470.981.140.460.610.6100.260.240.270.520.520.180.18-0.190.0650.050.050.0980.040.0880.0880.0680.0680.0120.012-0.002-0.002
EBITDA 14.357-5.53.222-18.143-14.528-23.74212.59396.39620.3351.203110.237227.7218.982263.49379.47178.211-16.259141.61352.2252.2238.78238.78232.38333.17710.688.4417.2167.21610.0764.046.5076.5074.4734.4731.2741.2740.4460.446
EBITDA Ratio 0.078-0.0290.022-0.157-0.122-0.2040.1130.9090.110.1880.2980.4390.03610.3590.372-0.07710.3680.3680.4020.4020.310.3220.2120.2470.2120.2120.3220.2090.2550.2550.240.240.1050.1050.0560.056